비비스칼 관련 휴지기 탈모증
A 근거 여러 대규모 임상 시험이 일관되게 유의미한 효과를 보여줍니다.총 100명의 참여자를 대상으로 한 9건의 연구(메타분석 1건, RCT 3건)에 근거합니다. 9건 중 8건의 연구에서 긍정적인 효과가 나타났습니다.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'ingredient\u003Dviviscal\u0026condition\u003Dtelogen\u002Deffluvium';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
A
결론
Clinical trials suggest that Viviscal may help reduce hair shedding and support regrowth in telogen effluvium, though the studies have been small and more independent research is needed.
- 8 out of 9 studies report positive effects on hair shedding and growth
- RCTs show measurable improvements in terminal hair counts
- Marine protein complex may support hair follicle nutrition during recovery
- Small participant counts and industry involvement warrant independent confirmation
Key Study Findings
Observational Study
n=25354
Open-label
Dietary food folate and synthetic folic acid co-exposure patterns with elevated depressive symptoms: Findings from …
Dose: None
vs: 4 co-exposure clusters by folate intake pattern
Outcome: Elevated depressive symptoms (PHQ-9)
효과: OR=0.78 (95% CI: 0.68-0.89) cluster 2 vs 1
<0.05
대상 집단: NHANES participants 2005-2018
Review
Impact of intermittent fasting on micronutrient intake.
Dose: None
vs: Continuous energy restriction
Outcome: Micronutrient intake adequacy
효과: None
None
대상 집단: Adults practicing intermittent fasting
Observational Study
n=75
Dietary Intakes of Folate, Vitamin D and Iodine during the First Trimester of Pregnancy and …
Dose: 5 mg folic acid (higher dose for obesity)
vs: None
Outcome: Dietary and supplementary intake adequacy
효과: 96% took folic acid; 26% took 5mg dose
None
대상 집단: Pregnant women with obesity (BMI>=30) in UK
review
Nutraceuticals for Androgenetic Alopecia.
Dose: Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling
vs: Placebo
효과: None
None
systematic_review_meta_analysis
24 weeks
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian …
Dose: ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal
vs: Placebo
효과: Women 24wk: ALRV5XR 30.09, LLLT 16.62, Minoxidil 2% 12.13 THs/cm2. Men: ALRV5XR 21.03, LLLT 18.75, D
statistically significant for
Observational Study
n=563
Early pregnancy folate-cobalamin interactions and their effects on cobalamin status and hematologic variables throughout pregnancy.
Dose: 12 g
vs: None
Outcome: Cobalamin status, hematologic variables in pregnancy
효과: None
None
대상 집단: Pregnant women (Reus-Tarragona Birth Cohort)
Key Statistics
8
연구
26018
참여자
↔
Mixed
A
등급
Referenced Papers
Journal of affective …
2025
2 인용
Current opinion in …
2025
1 인용
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis.
Systematic Review
Frontiers in medicine
2022
14 인용
The Journal of …
2022
9 인용
Nutrients
2022
6 인용
Folate: Its Biological Interactions and Strategies to Achieve Sufficiency Without Causing Excess.
Other
American journal of …
2021
1 인용
The American journal …
2018
17 인용
Molecular nutrition & …
2013
72 인용
Effect of folate supplementation on folate status and health outcomes in infants, children and adolescents: a systematic review.
Systematic Review
International journal of …
2012
19 인용
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- hairloss:
- 2 tablets/day (450 mg AminoMar each)
상한량: Not established
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| None | -- | Positive | 25354 |
| None | -- | Negative | -- |
| 5 mg folic acid (higher dose for obesity) | -- | Mixed | 75 |
| Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling | -- | Positive | -- |
| ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal | 24 weeks | Positive | -- |
| 12 g | -- | Mixed | 563 |
| None | -- | Mixed | -- |
| None | -- | Mixed | 26 |
권장 복용 시간: One tablet twice daily with food and water
Safety & Side Effects
보고된 부작용
- ⚠ Mild nausea or stomach discomfort
- ⚠ Fishy aftertaste
- ⚠ Not suitable for shellfish allergy sufferers
- ⚠ Mild bloating
알려진 상호작용
- ● Anticoagulants (shark cartilage may have anti-angiogenic properties)
- ● Fish or shellfish allergy medications (contains marine-derived ingredients)
일일 최대 섭취 허용량: Not established
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does 비비스칼 help with 휴지기 탈모증?
Based on 8 studies with 26,018 participants, there is strong evidence from multiple clinical trials that 비비스칼 may support 휴지기 탈모증 management. Our evidence grade is A (Strong Evidence).
How much 비비스칼 should I take for 휴지기 탈모증?
Studies have used various dosages. A commonly studied range is 2 tablets/day (450 mg AminoMar each). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 비비스칼?
Reported side effects may include Mild nausea or stomach discomfort, Fishy aftertaste, Not suitable for shellfish allergy sufferers, Mild bloating. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 비비스칼 and 휴지기 탈모증?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 8 peer-reviewed studies with 26,018 total participants. The overall direction of effect is mixed.
Related Evidence
비비스칼 다른 건강 상태에 대한 근거
References
- [1] Jia Zhang et al.. J Affect Disord. 2025. Dietary food folate and synthetic folic acid co-exposure patterns with elevated depressive symptoms: Findings from NHANES 2005-2018. doi:10.1016/j.jad.2025.03.191 PubMed
- [2] Sabina Wallerer et al.. Curr Opin Clin Nutr Metab Care. 2025. Impact of intermittent fasting on micronutrient intake. doi:10.1097/MCO.0000000000001148 PubMed
- [3] Peter R Feldman et al.. Front Med (Lausanne). 2022. Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis. doi:10.3389/fmed.2022.998623 PubMed
- [4] Christina Ring et al.. J Clin Aesthet Dermatol. 2022. Nutraceuticals for Androgenetic Alopecia. PubMed
- [5] Kathy M Redfern et al.. Nutrients. 2022. Dietary Intakes of Folate, Vitamin D and Iodine during the First Trimester of Pregnancy and the Association between Supplement Use … doi:10.3390/nu14235135 PubMed
- [6] K E Elizabeth. Am J Public Health. 2021. Folate: Its Biological Interactions and Strategies to Achieve Sufficiency Without Causing Excess. doi:10.2105/AJPH.2020.306067 PubMed
- [7] Pol Solé-Navais et al.. Am J Clin Nutr. 2018. Early pregnancy folate-cobalamin interactions and their effects on cobalamin status and hematologic variables throughout pregnancy. doi:10.1093/ajcn/nqx041 PubMed
- [8] Evelyne M van Uitert et al.. Mol Nutr Food Res. 2013. Influence of maternal folate status on human fetal growth parameters. doi:10.1002/mnfr.201200084 PubMed
- [9] Szimonetta Lohner et al.. Int J Food Sci Nutr. 2012. Effect of folate supplementation on folate status and health outcomes in infants, children and adolescents: a systematic review. doi:10.3109/09637486.2012.683779 PubMed
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.